However, ChIP-qPCR result indicated that the relative level of histone H3K9 tri-methylation (Figure 1E) in the promoter region of the MCP1 gene in CD14+ monocytes from CAD patients was significantly lower than in those from non-CAD patients. This evidence concerns the gene CCL2 and coronary artery disorder.